Výsledky vyhledávání - "single-inhaler triple therapy"

Akademický článek

Perspectives on Treatment Decisions, Preferences, and Adherence and Long-Term Management in Asthma and COPD: A Qualitative Analysis of Patient, Caregiver, and Healthcare Provider Insights

Autor: Román-Rodríguez M, McMullan I, Warner M, Compton CH, Tal-Singer R, Orlow JM, Han MK

Publikováno v: Patient Preference and Adherence, Vol Volume 18, Pp 2295-2306 (2024)

Miguel Román-Rodríguez,1,2 Ilona McMullan,3 Michelle Warner,3 Christopher H Compton,3 Ruth Tal-Singer,4 Jean M Orlow,5 MeiLan K Han6 1Centro de Salud Dra. Teresa Pique, Mallorca, Spain; 2Instituto de Investigación Sanitaria de las Islas Baleares (

Externí odkaz: https://doaj.org/article/492b448175c7416eac0f701163da95fe

Zobrazit plný text záznamu

Akademický článek

Evaluation of Adherence and Persistence to Triple Therapy in Patients with COPD: A German Claims Data Study

Autor: Vogelmeier CF, Beeh KM, Schultze M, Kossack N, Richter LM, Claussen J, Compton C, Noorduyn SG, Ismaila AS, Requena G

Publikováno v: International Journal of COPD, Vol Volume 19, Pp 1835-1848 (2024)

Claus F Vogelmeier,1 Kai-Michael Beeh,2 Michael Schultze,3 Nils Kossack,4 Lena M Richter,4 Jing Claussen,5 Chris Compton,6 Stephen G Noorduyn,7,8 Afisi S Ismaila,8,9 Gema Requena10 1Department of Medicine, Pulmonary and Critical Care Medicine, Univer

Externí odkaz: https://doaj.org/article/7bf00fe9cefe48c69896c215b1071c2d

Zobrazit plný text záznamu

Akademický článek

Outcomes Following Initiation of Triple Therapy with Fluticasone Furoate/Umeclidinium/Vilanterol versus Multiple-Inhaler Triple Therapy Among Medicare Advantage with Part D Beneficiaries and Those Commercially Enrolled for Health Care Insurance in the United States

Autor: Bogart M, Bengtson LG, Johnson MG, Bunner SH, Gronroos NN, DiRocco KK

Publikováno v: International Journal of COPD, Vol Volume 19, Pp 97-110 (2024)

Michael Bogart,1 Lindsay GS Bengtson,2 Mary G Johnson,2 Scott H Bunner,2 Noelle N Gronroos,2 Kristi K DiRocco3 1US Value Evidence & Outcomes, R&D US, GSK, Research Triangle Park, NC, USA; 2Health Economics and Outcomes Research, Optum, Eden Prairie,

Externí odkaz: https://doaj.org/article/6b75c671d245409e861dad6325781beb

Zobrazit plný text záznamu

Akademický článek

Benefit of Prompt Vs Delayed Initiation of Triple Therapy Following an Exacerbation in Patients with COPD in Japan: A Retrospective Cohort Study

Autor: Czira A, Akiyama S, Ishii T, Wood RP, Camidge LJ, Wallis H, Jennison T, Wild RAC, Yarita M, Hashimoto K, Rothnie KJ, Ismaila AS

Publikováno v: International Journal of COPD, Vol Volume 18, Pp 2933-2953 (2023)

Alexandrosz Czira,1 Shoko Akiyama,2 Takeo Ishii,2 Robert P Wood,3 Lucinda J Camidge,3 Hannah Wallis,3 Thomas Jennison,3 Rosie AC Wild,3 Masao Yarita,2 Kenichi Hashimoto,2 Kieran J Rothnie,1 Afisi S Ismaila4,5 1Value Evidence and Outcomes, R&D Global

Externí odkaz: https://doaj.org/article/fe79fecb33c34628af72c0385405c12b

Zobrazit plný text záznamu

Akademický článek

Cost-Effectiveness of Single-Inhaler Triple Therapy (FF/UMEC/VI) versus Tiotropium Monotherapy in Patients with Symptomatic Moderate-to-Very Severe COPD in the UK

Autor: Kendall R, Martin AA, Shah D, Shukla S, Compton C, Ismaila AS

Publikováno v: International Journal of COPD, Vol Volume 18, Pp 1815-1825 (2023)

Robyn Kendall,1 Alan A Martin,2 Dhvani Shah,3 Soham Shukla,4 Chris Compton,5 Afisi S Ismaila4,6 1ICON Health Economics, ICON plc, Vancouver, BC, Canada; 2Value Evidence and Outcomes, GSK, London, UK; 3ICON Health Economics, ICON plc, New York, NY, US

Externí odkaz: https://doaj.org/article/7922c7f2936b44bfaa3c521b489ec07c

Zobrazit plný text záznamu

Akademický článek

Real-World Treatment Patterns and Switching Following Moderate/Severe Chronic Obstructive Pulmonary Disease Exacerbation in Patients with Commercial or Medicare Insurance in the United States

Autor: Bogart M, Germain G, Laliberté F, Lejeune D, Duh MS

Publikováno v: International Journal of COPD, Vol Volume 18, Pp 1575-1586 (2023)

Michael Bogart,1 Guillaume Germain,2 François Laliberté,2 Dominique Lejeune,2 Mei Sheng Duh3 1U.S. Value Evidence and Outcomes, R&D US, GSK, Research Triangle Park, NC, USA; 2Groupe d’analyse, Ltée, Montréal, QC, Canada; 3Analysis Group, Boston

Externí odkaz: https://doaj.org/article/ebc2d56b898c40e8bf1ec9933c6381ad

Zobrazit plný text záznamu

Akademický článek

COPD Exacerbations, Costs, and Health Care Resource Utilization Before and After Initiation of Fluticasone Furoate/Umeclidinium/Vilanterol in Routine Care in the USA

Autor: Hanania NA, Bunner SH, Bengtson LGS, Ismaila AS, Bogart M

Publikováno v: International Journal of COPD, Vol Volume 18, Pp 407-418 (2023)

Nicola A Hanania,1 Scott H Bunner,2 Lindsay GS Bengtson,2 Afisi S Ismaila,3,4 Michael Bogart5 1Section of Pulmonary and Critical Care Medicine, Baylor College of Medicine, Houston, TX, USA; 2Optum, Eden Prairie, MN, USA; 3Value Evidence and Outcomes,

Externí odkaz: https://doaj.org/article/dda07446e3934f628d8997db14c3916f

Zobrazit plný text záznamu

Akademický článek

Cost-Effectiveness of Once-Daily Single-Inhaler COPD Triple Therapy in Spain: IMPACT Trial

Autor: Paly VF, Vallejo-Aparicio LA, Martin A, Izquierdo JL, Riesco JA, Soler-Cataluña JJ, Abreu C, Biswas C, Ismaila AS

Publikováno v: International Journal of COPD, Vol Volume 17, Pp 3097-3109 (2022)

Victoria Federico Paly,1 Laura Amanda Vallejo-Aparicio,2 Alan Martin,3 José Luis Izquierdo,4 Juan Antonio Riesco,5 Juan José Soler-Cataluña,6 Catarina Abreu,7 Chandroday Biswas,8 Afisi S Ismaila9,10 1ICON plc, Philadelphia, PA, USA; 2GSK, Madrid,

Externí odkaz: https://doaj.org/article/d375b105155d48d5b3f76699c30178ec

Zobrazit plný text záznamu

Akademický článek

Effectiveness of Extrafine Single Inhaler Triple Therapy in Chronic Obstructive Pulmonary Disease (COPD) in Germany – The TriOptimize Study

Autor: Gessner C, Trinkmann F, Bahari Javan S, Hövelmann R, Bogoevska V, Georges G, Nudo E, Criée CP

Publikováno v: International Journal of COPD, Vol Volume 17, Pp 3019-3031 (2022)

Christian Gessner,1 Frederik Trinkmann,2,3 Sanaz Bahari Javan,4 Raimund Hövelmann,4 Valentina Bogoevska,4 George Georges,5 Elena Nudo,6 Carl-Peter Criée7 1Pneumologische Praxis Leipzig, Universitätsklinikum Leipzig, Institut für Klinische Immunol

Externí odkaz: https://doaj.org/article/cfc52048361948df9ecf4986151bdb96

Zobrazit plný text záznamu

Akademický článek

Cost-Effectiveness Analysis of Triple Therapy with Budesonide/ Glycopyrronium/ Formoterol Fumarate versus Dual Therapy in Patients with Chronic Obstructive Pulmonary Disease in Spain

Autor: Trigueros JA, Garin N, Baloira A, Aceituno S, Calvo A, Prades M, Touron C, Martínez A, Torres C

Publikováno v: International Journal of COPD, Vol Volume 17, Pp 2905-2917 (2022)

Juan Antonio Trigueros,1 Noé Garin,2 Adolfo Baloira,3 Susana Aceituno,4 Ana Calvo,4 Miriam Prades,4 Carolina Touron,5 Anisia Martínez,5 Covadonga Torres5 1Health Center Menasalbas, Castilla-La Mancha Health Service, Toledo, Spain; 2Pharmacy Departm

Externí odkaz: https://doaj.org/article/78bd06d506ec4dc08cad0befafc25459

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání